What to know about GLP-1 use and adolescents
Dr. Rachel Pessah Pollack, an endocrinologist at NYU Langone Health, joins "CBS Mornings" to talk about a new study that showed promising results for GLP-1 use in adolescents.
Watch CBS News
Dr. Rachel Pessah Pollack, an endocrinologist at NYU Langone Health, joins "CBS Mornings" to talk about a new study that showed promising results for GLP-1 use in adolescents.
GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Dr. Rachel Pessah-Pollack joins CBS News' "The Daily Report" to discuss.
Dr. Jon LaPook joins "CBS Mornings" to break down the facts on a new warning about GLP-1 medications causing possible vision loss.
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
Dr. Rachel Pessah-Pollack discusses new guidance from the American College of Obstetricians and Gynecologists on GLP-1 use during pregnancy.
Growing usage of GLP-1 drugs for weight loss is reshaping how consumers shop for food and clothes, according to consulting firm EY-Parthenon.
New research on GLP-1 drug usage from EY-Parthenon shows that weight loss is now the most popular use of the drug once dedicated to diabetes patients. CBS News' Megan Cerullo reports on how the drugs are changing spending habits for users.
CBS News bought and tested vials marketed as an experimental weight loss drug from several sources to find out what was actually inside. Adam Yamaguchi shares the results on "CBS Mornings."
CBS News bought and tested vials marketed as an experimental weight loss drug from several sources to find out what was actually inside. Adam Yamaguchi shares the results on "CBS Mornings."
Two deaths were reported to the U.S. Food and Drug Administration that may be tied to the use of bootleg weight-loss drugs, documents reviewed by CBS News show.
Researchers will explore whether weight-loss drugs can deter risky or impulsive financial decisions. "It might be very good financially for the average person," one neuroscientist said.
Dr. Carolina Haass-Koffler, associate professor of psychiatry at Brown University, joins "The Daily Report" to explain how GLP-1 drugs could be used to treat addictions beyond excessive eating.
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."
Going on GLP-1 drugs significantly boosted unemployed women's chances of finding a job, according to a Harvard economist.
A study on the use of GLP-1 drugs shows they may be helping some women get ahead in their careers. CBS MoneyWatch reporter Megan Cerullo has more.
Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safety, who is eligible for the medication and more.
Here's how weight-loss drugs like Ozempic and Wegovy could reduce worker illness and save companies money.
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.
Medicare starts covering GLP-1 drugs on July 1. CBS News medical correspondent Dr. Céline Gounder has more.
Starting Wednesday, Medicare will help pay for some GLP-1 medications for weight loss. CBS News medical correspondent Dr. Celine Gounder explains what this means for patients.
For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.
More than 10% of Americans say they use GLP-1 drugs. But experts warn some side effects from the drugs could lead to dehydration, especially in extreme heat. Nutritionist Keri Glassman explains.
Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity. The FDA has approved GLP-1 drugs for weight loss among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who may be a candidate and more.
New data from the Office of Government Ethics shows that President Trump is ramping up his stock portfolio, with a CBS News analysis finding the president's investment accounts made 3,600 trades between January and March. CBS News senior investigative reporter Michael Kaplan has more.